Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
After Jenny Pearson’s daughter Elise first had a seizure at 16 months old, an MRI came back clean—her brain “looked beautiful,” Pearson recalled to Fierce. | After Jenny Pearson’s daughter Elise first had a seizure at 16 months old, an MRI came back clean—her brain “looked beautiful,” Pearson recalled to Fierce. But a follow-up scan a year later, just days before Thanksgiving, showed her frontal lobe was now awash in white splotches. A genetic test the week before Christmas gave a troubling diagnosis: Alexander disease.
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise

Zanvastro is now the first approved medicine for Alexander disease. Elsewhere, an immune system specialist posted positive…

The FDA approves Ionis' Zanvastro as the first treatment for Alexander disease, clearing the way for the company's first solo…

Last year, Johnson & Johnson arrived late to the party with Imaavy as the third FcRn blocker

Explore how AI, advanced analytics and real-world data can help identify rare disease patients earlier, reduce diagnostic delays…

After a surprise washout in a recent phase 3 trial of AstraZeneca and Ionis’ antisense oligonucleotide Wainua (eplontersen), the…

The Angelman Syndrome Foundation is partnering with startup Citizen Health to offer families access to Ari, an artificial…